On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...